George J. Barry, III
Kratz Barry LLPGeneral
Experience16 yrs
Elite Ratings
--
Practice Areas
Biotech (80 cases)
Chemical Biotech (7 cases)
Reexam/Aband. (5 cases)
Chemical (3 cases)
Comp. Arch. and Software (3 cases)
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:25-CV-00810 | Ferring Pharma Inc v. Alkem Laboratories Ltd | 07/02/25 | Challenger | |
| 1:25-CV-00385 | Almirall LLC v. Taro Pharma Inc | 03/28/25 | Challenger | |
| 1:24-CV-00924 | AbbVie Inc v. Hetero USA Inc | 08/08/24 | Challenger | |
| 1:23-CV-01372 | Bayer Pharma AG v. Aurobindo Pharma Ltd | 12/01/23 | Challenger | |
| 1:23-CV-01332 | AbbVie Inc v. Aurobindo Pharma USA Inc | 11/20/23 | Challenger | |
| 1:23-CV-00717 | Pfizer Inc v. Aurobindo Pharma Ltd | 06/30/23 | Challenger | |
| 1:22-CV-01461 | Amicus Therap US LLC v. Teva Pharma USA Inc | 11/07/22 | Challenger | |
| 1:22-CV-01442 | Pierre Fabre Medicament SAS v. Annora Pharma Pvt Ltd | 11/02/22 | ||
| 1:22-CV-01387 | Acadia Pharma Inc v. Aurobindo Pharma Ltd | 10/21/22 | Challenger | |
| 1:21-MD-03017 | In re: Xarelto (Rivaroxaban) ('310) Patent Litigation | 12/10/21 |